Detalhe da pesquisa
1.
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia.
Cancer
; 129(7): 992-1004, 2023 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36692409
2.
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.
Blood
; 138(26): 2753-2767, 2021 12 30.
Artigo
Inglês
| MEDLINE | ID: mdl-34724563
3.
Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile.
Ann Hematol
; 102(11): 3015-3023, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37535147
4.
Measurable Residual Disease (MRD) as a Surrogate Efficacy-Response Biomarker in AML.
Int J Mol Sci
; 24(4)2023 Feb 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36834477
5.
Clinical relevance of an objective flow cytometry approach based on limit of detection and limit of quantification for measurable residual disease assessment in acute myeloid leukemia. A post-hoc analysis of the GIMEMA AML1310 trial.
Haematologica
; 107(12): 2823-2833, 2022 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35295076
6.
Safety and effectiveness of ruxolitinib in the real-world management of polycythemia vera patients: a collaborative retrospective study by pH-negative MPN latial group.
Ann Hematol
; 101(6): 1275-1282, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35318505
7.
Pneumocystis jirovecii pneumonia in patients with previously untreated acute myeloid leukaemia.
Mycoses
; 65(2): 233-238, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34883533
8.
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia.
Blood
; 134(12): 935-945, 2019 09 19.
Artigo
Inglês
| MEDLINE | ID: mdl-31395600
9.
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.
Blood
; 131(12): 1275-1291, 2018 03 22.
Artigo
Inglês
| MEDLINE | ID: mdl-29330221
10.
Pulmonary infections in patients with myelodysplastic syndromes receiving frontline azacytidine treatment.
Hematol Oncol
; 38(2): 189-196, 2020 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-31891213
11.
Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia.
Ann Hematol
; 97(10): 1767-1774, 2018 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-29947973
12.
Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study.
Br J Haematol
; 177(5): 741-750, 2017 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28419408
13.
Pulmonary function testing for fitness assessment in asymptomatic adults with newly diagnosed acute myeloid leukemia.
Haematologica
; 107(11): 2752-2755, 2022 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35924584
14.
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems.
Am J Hematol
; 92(10): 1037-1046, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28675513
15.
Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study.
Int J Mol Sci
; 18(4)2017 Apr 14.
Artigo
Inglês
| MEDLINE | ID: mdl-28420120
16.
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia.
Haematologica
; 101(1): 77-85, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26565002
17.
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study.
Ann Hematol
; 95(7): 1059-65, 2016 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-27091349
18.
Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase.
Eur J Haematol
; 96(6): 643-9, 2016 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-26277477
19.
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia.
Eur J Haematol
; 96(4): 344-51, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26018238
20.
A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature.
Mycoses
; 59(9): 594-601, 2016 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-27061932